Global Immunity Support Ingredients Supply, Demand and Key Producers, 2026-2032
The global Immunity Support Ingredients market size is expected to reach $ 27090 million by 2032, rising at a market growth of 5.0% CAGR during the forecast period (2026-2032).
Immune-supporting ingredients are functional nutritional raw materials used in dietary supplements, functional foods and beverages, gummies, tablets, capsules, powders, and products for infant, geriatric, sports, and specialized nutrition. They serve to support normal immune system function, replenish key micronutrients, improve gut microbiota, provide bioactive plant compounds, and enhance daily health management. Key examples include Vitamin C, Vitamin D, zinc, selenium, probiotics, postbiotics, prebiotics, dietary fiber, yeast beta-glucan, lactoferrin, colostrum powder, elderberry extract, echinacea extract, curcumin, and nutritional premixes. In 2025, the global immune-supporting ingredient industry is projected to have an average capacity utilization rate of approximately 76.8% and a gross profit margin of about 31.5%. Upstream enterprises primarily engage in vitamin synthesis, mineral salt production, dairy processing, probiotic and yeast fermentation, plant cultivation and extraction, enzyme production, encapsulation and packaging materials, and testing services. Downstream sectors mainly include dietary supplements, functional foods and beverages, dairy products, nutrition for infants and the elderly, sports nutrition, gummies, dual-use medicinal and food products, and contract manufacturing. The product cost structure is approximately as follows: vitamin and mineral raw materials (24%); probiotic strains and fermentation costs (15%); plant extracts and dairy-derived bioactive ingredients (18%); yeast beta-glucan, prebiotics, and dietary fiber (13%); labor and manufacturing overhead (8%); testing, certification, and regulatory compliance (6%); energy and environmental protection (5%); packaging, warehousing, and logistics (5%); and R&D, application support, and administrative expenses (6%). The list of required ingredients includes Vitamin C, Vitamin D, zinc, selenium, vitamin-mineral premixes, probiotic powder, postbiotics, inulin, fructooligosaccharides (FOS), yeast beta-glucan, lactoferrin, colostrum powder, elderberry extract, echinacea extract, and raw materials for immune-support gummy formulations. Downstream clients include brands of dietary supplements, functional beverages, functional foods, nutritional gummies, infant and child nutrition products, senior nutrition products, sports nutrition, and health foods, as well as contract manufacturers and premix formulators. Business opportunities are driven by policies promoting healthy aging, child nutrition, the standardization of health foods, sugar reduction, and the growing demand for daily health management. Technological innovation is driven by advancements in strain screening, postbiotic stabilization, lactoferrin isolation and purification, standardization of plant extracts, microencapsulation, synergistic ingredient combinations, and dosage form optimization. Meanwhile, shifting consumer demands are driving product upgrades?moving from simple vitamin supplementation toward scientifically formulated, multi-ingredient products targeting gut health and immunity (for children and seniors) and formats such as ready-to-eat gummies and ready-to-drink beverages.
The immune support ingredient sector is a growth-oriented functional nutrition market built upon a mature foundation; overall demand has shifted from the short-term, emergency-driven consumption seen during the pandemic toward consumption patterns characterized by daily use, specific usage scenarios, and evidence-based efficacy. Vitamins C and D, zinc, and selenium remain the staples of basic demand, featuring transparent pricing, mature supply chains, and competition driven primarily by cost and scale. Conversely, ingredients such as probiotics, postbiotics, lactoferrin, yeast beta-glucan, elderberry, echinacea, inulin, and complex premixes represent higher value-added segments, where customers prioritize scientific evidence, active ingredient stability, taste, dosage form suitability, and regulatory compliance. Over the next six to eight years, the immune health concept will move beyond simple 'immune-boosting' claims to drive growth; instead, it will integrate with areas such as gut health, pediatric growth, elderly nutrition, sports recovery, sleep and stress management, and low-sugar functional foods to meet multifaceted, scenario-based demands. While North American and European markets place greater emphasis on clinical evidence, branded ingredients, and compliant health claims, China and India hold distinct advantages in the supply of vitamins, botanical extracts, yeast-based ingredients, and cost-competitive raw materials; meanwhile, Japan, South Korea, and Taiwan excel in probiotics and fermented nutritional products. Future industry growth is expected to remain steady, with leading enterprises enhancing their bargaining power through diversified product portfolios, global customer certifications, ingredient traceability, formulation services, and regulatory support. Small and medium-sized enterprises, meanwhile, will need to seek differentiation opportunities in specialized botanical extracts, patented strains, customized premixes, and regional supply chain capabilities.
This report studies the global Immunity Support Ingredients demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Immunity Support Ingredients, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immunity Support Ingredients that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Immunity Support Ingredients total market, 2021-2032, (USD Million)
Global Immunity Support Ingredients total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Immunity Support Ingredients total market, key domestic companies, and share, (USD Million)
Global Immunity Support Ingredients revenue by player, revenue and market share 2021-2026, (USD Million)
Global Immunity Support Ingredients total market by Type, CAGR, 2021-2032, (USD Million)
Global Immunity Support Ingredients total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Immunity Support Ingredients market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DSM (NL), BASF SE (DE), Archer Daniels Midland Company (US), International Flavors & Fragrances Inc. (US), Kerry Group plc (IE), Novonesis (DK), FrieslandCampina Ingredients (NL), Fonterra Co-operative Group Limited (NZ), Arla Foods Ingredients Group P/S (DK), BENEO GmbH (DE), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Immunity Support Ingredients market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Immunity Support Ingredients Market, By Region:
1. How big is the global Immunity Support Ingredients market?
2. What is the demand of the global Immunity Support Ingredients market?
3. What is the year over year growth of the global Immunity Support Ingredients market?
4. What is the total value of the global Immunity Support Ingredients market?
5. Who are the Major Players in the global Immunity Support Ingredients market?
6. What are the growth factors driving the market demand?
Immune-supporting ingredients are functional nutritional raw materials used in dietary supplements, functional foods and beverages, gummies, tablets, capsules, powders, and products for infant, geriatric, sports, and specialized nutrition. They serve to support normal immune system function, replenish key micronutrients, improve gut microbiota, provide bioactive plant compounds, and enhance daily health management. Key examples include Vitamin C, Vitamin D, zinc, selenium, probiotics, postbiotics, prebiotics, dietary fiber, yeast beta-glucan, lactoferrin, colostrum powder, elderberry extract, echinacea extract, curcumin, and nutritional premixes. In 2025, the global immune-supporting ingredient industry is projected to have an average capacity utilization rate of approximately 76.8% and a gross profit margin of about 31.5%. Upstream enterprises primarily engage in vitamin synthesis, mineral salt production, dairy processing, probiotic and yeast fermentation, plant cultivation and extraction, enzyme production, encapsulation and packaging materials, and testing services. Downstream sectors mainly include dietary supplements, functional foods and beverages, dairy products, nutrition for infants and the elderly, sports nutrition, gummies, dual-use medicinal and food products, and contract manufacturing. The product cost structure is approximately as follows: vitamin and mineral raw materials (24%); probiotic strains and fermentation costs (15%); plant extracts and dairy-derived bioactive ingredients (18%); yeast beta-glucan, prebiotics, and dietary fiber (13%); labor and manufacturing overhead (8%); testing, certification, and regulatory compliance (6%); energy and environmental protection (5%); packaging, warehousing, and logistics (5%); and R&D, application support, and administrative expenses (6%). The list of required ingredients includes Vitamin C, Vitamin D, zinc, selenium, vitamin-mineral premixes, probiotic powder, postbiotics, inulin, fructooligosaccharides (FOS), yeast beta-glucan, lactoferrin, colostrum powder, elderberry extract, echinacea extract, and raw materials for immune-support gummy formulations. Downstream clients include brands of dietary supplements, functional beverages, functional foods, nutritional gummies, infant and child nutrition products, senior nutrition products, sports nutrition, and health foods, as well as contract manufacturers and premix formulators. Business opportunities are driven by policies promoting healthy aging, child nutrition, the standardization of health foods, sugar reduction, and the growing demand for daily health management. Technological innovation is driven by advancements in strain screening, postbiotic stabilization, lactoferrin isolation and purification, standardization of plant extracts, microencapsulation, synergistic ingredient combinations, and dosage form optimization. Meanwhile, shifting consumer demands are driving product upgrades?moving from simple vitamin supplementation toward scientifically formulated, multi-ingredient products targeting gut health and immunity (for children and seniors) and formats such as ready-to-eat gummies and ready-to-drink beverages.
The immune support ingredient sector is a growth-oriented functional nutrition market built upon a mature foundation; overall demand has shifted from the short-term, emergency-driven consumption seen during the pandemic toward consumption patterns characterized by daily use, specific usage scenarios, and evidence-based efficacy. Vitamins C and D, zinc, and selenium remain the staples of basic demand, featuring transparent pricing, mature supply chains, and competition driven primarily by cost and scale. Conversely, ingredients such as probiotics, postbiotics, lactoferrin, yeast beta-glucan, elderberry, echinacea, inulin, and complex premixes represent higher value-added segments, where customers prioritize scientific evidence, active ingredient stability, taste, dosage form suitability, and regulatory compliance. Over the next six to eight years, the immune health concept will move beyond simple 'immune-boosting' claims to drive growth; instead, it will integrate with areas such as gut health, pediatric growth, elderly nutrition, sports recovery, sleep and stress management, and low-sugar functional foods to meet multifaceted, scenario-based demands. While North American and European markets place greater emphasis on clinical evidence, branded ingredients, and compliant health claims, China and India hold distinct advantages in the supply of vitamins, botanical extracts, yeast-based ingredients, and cost-competitive raw materials; meanwhile, Japan, South Korea, and Taiwan excel in probiotics and fermented nutritional products. Future industry growth is expected to remain steady, with leading enterprises enhancing their bargaining power through diversified product portfolios, global customer certifications, ingredient traceability, formulation services, and regulatory support. Small and medium-sized enterprises, meanwhile, will need to seek differentiation opportunities in specialized botanical extracts, patented strains, customized premixes, and regional supply chain capabilities.
This report studies the global Immunity Support Ingredients demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Immunity Support Ingredients, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immunity Support Ingredients that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Immunity Support Ingredients total market, 2021-2032, (USD Million)
Global Immunity Support Ingredients total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Immunity Support Ingredients total market, key domestic companies, and share, (USD Million)
Global Immunity Support Ingredients revenue by player, revenue and market share 2021-2026, (USD Million)
Global Immunity Support Ingredients total market by Type, CAGR, 2021-2032, (USD Million)
Global Immunity Support Ingredients total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Immunity Support Ingredients market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DSM (NL), BASF SE (DE), Archer Daniels Midland Company (US), International Flavors & Fragrances Inc. (US), Kerry Group plc (IE), Novonesis (DK), FrieslandCampina Ingredients (NL), Fonterra Co-operative Group Limited (NZ), Arla Foods Ingredients Group P/S (DK), BENEO GmbH (DE), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Immunity Support Ingredients market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Immunity Support Ingredients Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Vitamin C
- Vitamin E
- Other Vitamins
- Beta Glucans
- Carotenoids
- Phytosterols
- Omega-3 Fatty Acids
- Liquid
- Powder
- Capsule/Tablet
- ?95%
- ?98%
- ?99%
- Other
- Nutrition Supplements
- Foods & Beverages
- Pharmaceuticals
- Feeds
- Pet Foods
- Personal Care Products
- Other
- DSM (NL)
- BASF SE (DE)
- Archer Daniels Midland Company (US)
- International Flavors & Fragrances Inc. (US)
- Kerry Group plc (IE)
- Novonesis (DK)
- FrieslandCampina Ingredients (NL)
- Fonterra Co-operative Group Limited (NZ)
- Arla Foods Ingredients Group P/S (DK)
- BENEO GmbH (DE)
- Angel Yeast Co., Ltd. (CN)
- Lesaffre (FR)
- Balchem Corporation (US)
- Glanbia plc (IE)
- MartinBauer Group (US)
- Indena S.p.A. (IT)
- Sabinsa Corporation (US)
- Euromed S.A. (ES)
- Probi AB (SE)
- BioGaia AB (SE)
- Morinaga Milk Industry Co., Ltd. (JP)
- Lallemand Inc. (CA)
- Zhejiang NHU Co., Ltd. (CN)
- CSPC Pharmaceutical Group Limited (CN)
- Northeast Pharmaceutical Group Co., Ltd. (CN)
- Zhejiang Medicine Co., Ltd. (CN)
- Roquette Fr?res (FR)
- Tate & Lyle PLC (GB)
- Hunan Green-Spring Biotechnology Co., Ltd. (CN)
- Croda International Plc (GB)
- EPAX AS (NO)
- Bluestar Adisseo Company (CN)
- Raisio plc (FI)
1. How big is the global Immunity Support Ingredients market?
2. What is the demand of the global Immunity Support Ingredients market?
3. What is the year over year growth of the global Immunity Support Ingredients market?
4. What is the total value of the global Immunity Support Ingredients market?
5. Who are the Major Players in the global Immunity Support Ingredients market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Immunity Support Ingredients Introduction
1.2 World Immunity Support Ingredients Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Immunity Support Ingredients Total Market by Region (by Headquarter Location)
1.3.1 World Immunity Support Ingredients Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Immunity Support Ingredients Revenue (2021-2032)
1.3.3 China Based Company Immunity Support Ingredients Revenue (2021-2032)
1.3.4 Europe Based Company Immunity Support Ingredients Revenue (2021-2032)
1.3.5 Japan Based Company Immunity Support Ingredients Revenue (2021-2032)
1.3.6 South Korea Based Company Immunity Support Ingredients Revenue (2021-2032)
1.3.7 ASEAN Based Company Immunity Support Ingredients Revenue (2021-2032)
1.3.8 India Based Company Immunity Support Ingredients Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immunity Support Ingredients Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Immunity Support Ingredients Consumption Value (2021-2032)
2.2 World Immunity Support Ingredients Consumption Value by Region
2.2.1 World Immunity Support Ingredients Consumption Value by Region (2021-2026)
2.2.2 World Immunity Support Ingredients Consumption Value Forecast by Region (2027-2032)
2.3 United States Immunity Support Ingredients Consumption Value (2021-2032)
2.4 China Immunity Support Ingredients Consumption Value (2021-2032)
2.5 Europe Immunity Support Ingredients Consumption Value (2021-2032)
2.6 Japan Immunity Support Ingredients Consumption Value (2021-2032)
2.7 South Korea Immunity Support Ingredients Consumption Value (2021-2032)
2.8 ASEAN Immunity Support Ingredients Consumption Value (2021-2032)
2.9 India Immunity Support Ingredients Consumption Value (2021-2032)
3 WORLD IMMUNITY SUPPORT INGREDIENTS COMPANIES COMPETITIVE ANALYSIS
3.1 World Immunity Support Ingredients Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Immunity Support Ingredients Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Immunity Support Ingredients in 2025
3.2.3 Global Concentration Ratios (CR8) for Immunity Support Ingredients in 2025
3.3 Immunity Support Ingredients Company Evaluation Quadrant
3.4 Immunity Support Ingredients Market: Overall Company Footprint Analysis
3.4.1 Immunity Support Ingredients Market: Region Footprint
3.4.2 Immunity Support Ingredients Market: Company Product Type Footprint
3.4.3 Immunity Support Ingredients Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Immunity Support Ingredients Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Immunity Support Ingredients Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Immunity Support Ingredients Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Immunity Support Ingredients Consumption Value Comparison
4.2.1 United States VS China: Immunity Support Ingredients Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Immunity Support Ingredients Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Immunity Support Ingredients Companies and Market Share, 2021-2026
4.3.1 United States Based Immunity Support Ingredients Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Immunity Support Ingredients Revenue, (2021-2026)
4.4 China Based Companies Immunity Support Ingredients Revenue and Market Share, 2021-2026
4.4.1 China Based Immunity Support Ingredients Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Immunity Support Ingredients Revenue, (2021-2026)
4.5 Rest of World Based Immunity Support Ingredients Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Immunity Support Ingredients Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Immunity Support Ingredients Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Immunity Support Ingredients Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Vitamin C
5.2.2 Vitamin E
5.2.3 Other Vitamins
5.2.4 Beta Glucans
5.2.5 Carotenoids
5.2.6 Phytosterols
5.2.7 Omega-3 Fatty Acids
5.3 Market Segment by Type
5.3.1 World Immunity Support Ingredients Market Size by Type (2021-2026)
5.3.2 World Immunity Support Ingredients Market Size by Type (2027-2032)
5.3.3 World Immunity Support Ingredients Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Immunity Support Ingredients Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Liquid
6.2.2 Powder
6.2.3 Capsule/Tablet
6.3 Market Segment by Dosage Form
6.3.1 World Immunity Support Ingredients Market Size by Dosage Form (2021-2026)
6.3.2 World Immunity Support Ingredients Market Size by Dosage Form (2027-2032)
6.3.3 World Immunity Support Ingredients Market Size Market Share by Dosage Form (2027-2032)
7 MARKET ANALYSIS BY PURITY
7.1 World Immunity Support Ingredients Market Size Overview by Purity: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Purity
7.2.1 ?95%
7.2.2 ?98%
7.2.3 ?99%
7.2.4 Other
7.3 Market Segment by Purity
7.3.1 World Immunity Support Ingredients Market Size by Purity (2021-2026)
7.3.2 World Immunity Support Ingredients Market Size by Purity (2027-2032)
7.3.3 World Immunity Support Ingredients Market Size Market Share by Purity (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Immunity Support Ingredients Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Nutrition Supplements
8.2.2 Foods & Beverages
8.2.3 Pharmaceuticals
8.2.4 Feeds
8.2.5 Pet Foods
8.2.6 Personal Care Products
8.2.7 Other
8.3 Market Segment by Application
8.3.1 World Immunity Support Ingredients Market Size by Application (2021-2026)
8.3.2 World Immunity Support Ingredients Market Size by Application (2027-2032)
8.3.3 World Immunity Support Ingredients Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 DSM (NL)
9.1.1 DSM (NL) Details
9.1.2 DSM (NL) Major Business
9.1.3 DSM (NL) Immunity Support Ingredients Product and Services
9.1.4 DSM (NL) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 DSM (NL) Recent Developments/Updates
9.1.6 DSM (NL) Competitive Strengths & Weaknesses
9.2 BASF SE (DE)
9.2.1 BASF SE (DE) Details
9.2.2 BASF SE (DE) Major Business
9.2.3 BASF SE (DE) Immunity Support Ingredients Product and Services
9.2.4 BASF SE (DE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 BASF SE (DE) Recent Developments/Updates
9.2.6 BASF SE (DE) Competitive Strengths & Weaknesses
9.3 Archer Daniels Midland Company (US)
9.3.1 Archer Daniels Midland Company (US) Details
9.3.2 Archer Daniels Midland Company (US) Major Business
9.3.3 Archer Daniels Midland Company (US) Immunity Support Ingredients Product and Services
9.3.4 Archer Daniels Midland Company (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Archer Daniels Midland Company (US) Recent Developments/Updates
9.3.6 Archer Daniels Midland Company (US) Competitive Strengths & Weaknesses
9.4 International Flavors & Fragrances Inc. (US)
9.4.1 International Flavors & Fragrances Inc. (US) Details
9.4.2 International Flavors & Fragrances Inc. (US) Major Business
9.4.3 International Flavors & Fragrances Inc. (US) Immunity Support Ingredients Product and Services
9.4.4 International Flavors & Fragrances Inc. (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 International Flavors & Fragrances Inc. (US) Recent Developments/Updates
9.4.6 International Flavors & Fragrances Inc. (US) Competitive Strengths & Weaknesses
9.5 Kerry Group plc (IE)
9.5.1 Kerry Group plc (IE) Details
9.5.2 Kerry Group plc (IE) Major Business
9.5.3 Kerry Group plc (IE) Immunity Support Ingredients Product and Services
9.5.4 Kerry Group plc (IE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Kerry Group plc (IE) Recent Developments/Updates
9.5.6 Kerry Group plc (IE) Competitive Strengths & Weaknesses
9.6 Novonesis (DK)
9.6.1 Novonesis (DK) Details
9.6.2 Novonesis (DK) Major Business
9.6.3 Novonesis (DK) Immunity Support Ingredients Product and Services
9.6.4 Novonesis (DK) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Novonesis (DK) Recent Developments/Updates
9.6.6 Novonesis (DK) Competitive Strengths & Weaknesses
9.7 FrieslandCampina Ingredients (NL)
9.7.1 FrieslandCampina Ingredients (NL) Details
9.7.2 FrieslandCampina Ingredients (NL) Major Business
9.7.3 FrieslandCampina Ingredients (NL) Immunity Support Ingredients Product and Services
9.7.4 FrieslandCampina Ingredients (NL) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 FrieslandCampina Ingredients (NL) Recent Developments/Updates
9.7.6 FrieslandCampina Ingredients (NL) Competitive Strengths & Weaknesses
9.8 Fonterra Co-operative Group Limited (NZ)
9.8.1 Fonterra Co-operative Group Limited (NZ) Details
9.8.2 Fonterra Co-operative Group Limited (NZ) Major Business
9.8.3 Fonterra Co-operative Group Limited (NZ) Immunity Support Ingredients Product and Services
9.8.4 Fonterra Co-operative Group Limited (NZ) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Fonterra Co-operative Group Limited (NZ) Recent Developments/Updates
9.8.6 Fonterra Co-operative Group Limited (NZ) Competitive Strengths & Weaknesses
9.9 Arla Foods Ingredients Group P/S (DK)
9.9.1 Arla Foods Ingredients Group P/S (DK) Details
9.9.2 Arla Foods Ingredients Group P/S (DK) Major Business
9.9.3 Arla Foods Ingredients Group P/S (DK) Immunity Support Ingredients Product and Services
9.9.4 Arla Foods Ingredients Group P/S (DK) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Arla Foods Ingredients Group P/S (DK) Recent Developments/Updates
9.9.6 Arla Foods Ingredients Group P/S (DK) Competitive Strengths & Weaknesses
9.10 BENEO GmbH (DE)
9.10.1 BENEO GmbH (DE) Details
9.10.2 BENEO GmbH (DE) Major Business
9.10.3 BENEO GmbH (DE) Immunity Support Ingredients Product and Services
9.10.4 BENEO GmbH (DE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 BENEO GmbH (DE) Recent Developments/Updates
9.10.6 BENEO GmbH (DE) Competitive Strengths & Weaknesses
9.11 Angel Yeast Co., Ltd. (CN)
9.11.1 Angel Yeast Co., Ltd. (CN) Details
9.11.2 Angel Yeast Co., Ltd. (CN) Major Business
9.11.3 Angel Yeast Co., Ltd. (CN) Immunity Support Ingredients Product and Services
9.11.4 Angel Yeast Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Angel Yeast Co., Ltd. (CN) Recent Developments/Updates
9.11.6 Angel Yeast Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.12 Lesaffre (FR)
9.12.1 Lesaffre (FR) Details
9.12.2 Lesaffre (FR) Major Business
9.12.3 Lesaffre (FR) Immunity Support Ingredients Product and Services
9.12.4 Lesaffre (FR) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Lesaffre (FR) Recent Developments/Updates
9.12.6 Lesaffre (FR) Competitive Strengths & Weaknesses
9.13 Balchem Corporation (US)
9.13.1 Balchem Corporation (US) Details
9.13.2 Balchem Corporation (US) Major Business
9.13.3 Balchem Corporation (US) Immunity Support Ingredients Product and Services
9.13.4 Balchem Corporation (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Balchem Corporation (US) Recent Developments/Updates
9.13.6 Balchem Corporation (US) Competitive Strengths & Weaknesses
9.14 Glanbia plc (IE)
9.14.1 Glanbia plc (IE) Details
9.14.2 Glanbia plc (IE) Major Business
9.14.3 Glanbia plc (IE) Immunity Support Ingredients Product and Services
9.14.4 Glanbia plc (IE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Glanbia plc (IE) Recent Developments/Updates
9.14.6 Glanbia plc (IE) Competitive Strengths & Weaknesses
9.15 MartinBauer Group (US)
9.15.1 MartinBauer Group (US) Details
9.15.2 MartinBauer Group (US) Major Business
9.15.3 MartinBauer Group (US) Immunity Support Ingredients Product and Services
9.15.4 MartinBauer Group (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 MartinBauer Group (US) Recent Developments/Updates
9.15.6 MartinBauer Group (US) Competitive Strengths & Weaknesses
9.16 Indena S.p.A. (IT)
9.16.1 Indena S.p.A. (IT) Details
9.16.2 Indena S.p.A. (IT) Major Business
9.16.3 Indena S.p.A. (IT) Immunity Support Ingredients Product and Services
9.16.4 Indena S.p.A. (IT) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Indena S.p.A. (IT) Recent Developments/Updates
9.16.6 Indena S.p.A. (IT) Competitive Strengths & Weaknesses
9.17 Sabinsa Corporation (US)
9.17.1 Sabinsa Corporation (US) Details
9.17.2 Sabinsa Corporation (US) Major Business
9.17.3 Sabinsa Corporation (US) Immunity Support Ingredients Product and Services
9.17.4 Sabinsa Corporation (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Sabinsa Corporation (US) Recent Developments/Updates
9.17.6 Sabinsa Corporation (US) Competitive Strengths & Weaknesses
9.18 Euromed S.A. (ES)
9.18.1 Euromed S.A. (ES) Details
9.18.2 Euromed S.A. (ES) Major Business
9.18.3 Euromed S.A. (ES) Immunity Support Ingredients Product and Services
9.18.4 Euromed S.A. (ES) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Euromed S.A. (ES) Recent Developments/Updates
9.18.6 Euromed S.A. (ES) Competitive Strengths & Weaknesses
9.19 Probi AB (SE)
9.19.1 Probi AB (SE) Details
9.19.2 Probi AB (SE) Major Business
9.19.3 Probi AB (SE) Immunity Support Ingredients Product and Services
9.19.4 Probi AB (SE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Probi AB (SE) Recent Developments/Updates
9.19.6 Probi AB (SE) Competitive Strengths & Weaknesses
9.20 BioGaia AB (SE)
9.20.1 BioGaia AB (SE) Details
9.20.2 BioGaia AB (SE) Major Business
9.20.3 BioGaia AB (SE) Immunity Support Ingredients Product and Services
9.20.4 BioGaia AB (SE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 BioGaia AB (SE) Recent Developments/Updates
9.20.6 BioGaia AB (SE) Competitive Strengths & Weaknesses
9.21 Morinaga Milk Industry Co., Ltd. (JP)
9.21.1 Morinaga Milk Industry Co., Ltd. (JP) Details
9.21.2 Morinaga Milk Industry Co., Ltd. (JP) Major Business
9.21.3 Morinaga Milk Industry Co., Ltd. (JP) Immunity Support Ingredients Product and Services
9.21.4 Morinaga Milk Industry Co., Ltd. (JP) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Morinaga Milk Industry Co., Ltd. (JP) Recent Developments/Updates
9.21.6 Morinaga Milk Industry Co., Ltd. (JP) Competitive Strengths & Weaknesses
9.22 Lallemand Inc. (CA)
9.22.1 Lallemand Inc. (CA) Details
9.22.2 Lallemand Inc. (CA) Major Business
9.22.3 Lallemand Inc. (CA) Immunity Support Ingredients Product and Services
9.22.4 Lallemand Inc. (CA) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Lallemand Inc. (CA) Recent Developments/Updates
9.22.6 Lallemand Inc. (CA) Competitive Strengths & Weaknesses
9.23 Zhejiang NHU Co., Ltd. (CN)
9.23.1 Zhejiang NHU Co., Ltd. (CN) Details
9.23.2 Zhejiang NHU Co., Ltd. (CN) Major Business
9.23.3 Zhejiang NHU Co., Ltd. (CN) Immunity Support Ingredients Product and Services
9.23.4 Zhejiang NHU Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Zhejiang NHU Co., Ltd. (CN) Recent Developments/Updates
9.23.6 Zhejiang NHU Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.24 CSPC Pharmaceutical Group Limited (CN)
9.24.1 CSPC Pharmaceutical Group Limited (CN) Details
9.24.2 CSPC Pharmaceutical Group Limited (CN) Major Business
9.24.3 CSPC Pharmaceutical Group Limited (CN) Immunity Support Ingredients Product and Services
9.24.4 CSPC Pharmaceutical Group Limited (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 CSPC Pharmaceutical Group Limited (CN) Recent Developments/Updates
9.24.6 CSPC Pharmaceutical Group Limited (CN) Competitive Strengths & Weaknesses
9.25 Northeast Pharmaceutical Group Co., Ltd. (CN)
9.25.1 Northeast Pharmaceutical Group Co., Ltd. (CN) Details
9.25.2 Northeast Pharmaceutical Group Co., Ltd. (CN) Major Business
9.25.3 Northeast Pharmaceutical Group Co., Ltd. (CN) Immunity Support Ingredients Product and Services
9.25.4 Northeast Pharmaceutical Group Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Northeast Pharmaceutical Group Co., Ltd. (CN) Recent Developments/Updates
9.25.6 Northeast Pharmaceutical Group Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.26 Zhejiang Medicine Co., Ltd. (CN)
9.26.1 Zhejiang Medicine Co., Ltd. (CN) Details
9.26.2 Zhejiang Medicine Co., Ltd. (CN) Major Business
9.26.3 Zhejiang Medicine Co., Ltd. (CN) Immunity Support Ingredients Product and Services
9.26.4 Zhejiang Medicine Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Zhejiang Medicine Co., Ltd. (CN) Recent Developments/Updates
9.26.6 Zhejiang Medicine Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.27 Roquette Fr?res (FR)
9.27.1 Roquette Fr?res (FR) Details
9.27.2 Roquette Fr?res (FR) Major Business
9.27.3 Roquette Fr?res (FR) Immunity Support Ingredients Product and Services
9.27.4 Roquette Fr?res (FR) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Roquette Fr?res (FR) Recent Developments/Updates
9.27.6 Roquette Fr?res (FR) Competitive Strengths & Weaknesses
9.28 Tate & Lyle PLC (GB)
9.28.1 Tate & Lyle PLC (GB) Details
9.28.2 Tate & Lyle PLC (GB) Major Business
9.28.3 Tate & Lyle PLC (GB) Immunity Support Ingredients Product and Services
9.28.4 Tate & Lyle PLC (GB) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Tate & Lyle PLC (GB) Recent Developments/Updates
9.28.6 Tate & Lyle PLC (GB) Competitive Strengths & Weaknesses
9.29 Hunan Green-Spring Biotechnology Co., Ltd. (CN)
9.29.1 Hunan Green-Spring Biotechnology Co., Ltd. (CN) Details
9.29.2 Hunan Green-Spring Biotechnology Co., Ltd. (CN) Major Business
9.29.3 Hunan Green-Spring Biotechnology Co., Ltd. (CN) Immunity Support Ingredients Product and Services
9.29.4 Hunan Green-Spring Biotechnology Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 Hunan Green-Spring Biotechnology Co., Ltd. (CN) Recent Developments/Updates
9.29.6 Hunan Green-Spring Biotechnology Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.30 Croda International Plc (GB)
9.30.1 Croda International Plc (GB) Details
9.30.2 Croda International Plc (GB) Major Business
9.30.3 Croda International Plc (GB) Immunity Support Ingredients Product and Services
9.30.4 Croda International Plc (GB) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Croda International Plc (GB) Recent Developments/Updates
9.30.6 Croda International Plc (GB) Competitive Strengths & Weaknesses
9.31 EPAX AS (NO)
9.31.1 EPAX AS (NO) Details
9.31.2 EPAX AS (NO) Major Business
9.31.3 EPAX AS (NO) Immunity Support Ingredients Product and Services
9.31.4 EPAX AS (NO) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 EPAX AS (NO) Recent Developments/Updates
9.31.6 EPAX AS (NO) Competitive Strengths & Weaknesses
9.32 Bluestar Adisseo Company (CN)
9.32.1 Bluestar Adisseo Company (CN) Details
9.32.2 Bluestar Adisseo Company (CN) Major Business
9.32.3 Bluestar Adisseo Company (CN) Immunity Support Ingredients Product and Services
9.32.4 Bluestar Adisseo Company (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 Bluestar Adisseo Company (CN) Recent Developments/Updates
9.32.6 Bluestar Adisseo Company (CN) Competitive Strengths & Weaknesses
9.33 Raisio plc (FI)
9.33.1 Raisio plc (FI) Details
9.33.2 Raisio plc (FI) Major Business
9.33.3 Raisio plc (FI) Immunity Support Ingredients Product and Services
9.33.4 Raisio plc (FI) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 Raisio plc (FI) Recent Developments/Updates
9.33.6 Raisio plc (FI) Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Immunity Support Ingredients Industry Chain
10.2 Immunity Support Ingredients Upstream Analysis
10.3 Immunity Support Ingredients Midstream Analysis
10.4 Immunity Support Ingredients Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Immunity Support Ingredients Introduction
1.2 World Immunity Support Ingredients Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Immunity Support Ingredients Total Market by Region (by Headquarter Location)
1.3.1 World Immunity Support Ingredients Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Immunity Support Ingredients Revenue (2021-2032)
1.3.3 China Based Company Immunity Support Ingredients Revenue (2021-2032)
1.3.4 Europe Based Company Immunity Support Ingredients Revenue (2021-2032)
1.3.5 Japan Based Company Immunity Support Ingredients Revenue (2021-2032)
1.3.6 South Korea Based Company Immunity Support Ingredients Revenue (2021-2032)
1.3.7 ASEAN Based Company Immunity Support Ingredients Revenue (2021-2032)
1.3.8 India Based Company Immunity Support Ingredients Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immunity Support Ingredients Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Immunity Support Ingredients Consumption Value (2021-2032)
2.2 World Immunity Support Ingredients Consumption Value by Region
2.2.1 World Immunity Support Ingredients Consumption Value by Region (2021-2026)
2.2.2 World Immunity Support Ingredients Consumption Value Forecast by Region (2027-2032)
2.3 United States Immunity Support Ingredients Consumption Value (2021-2032)
2.4 China Immunity Support Ingredients Consumption Value (2021-2032)
2.5 Europe Immunity Support Ingredients Consumption Value (2021-2032)
2.6 Japan Immunity Support Ingredients Consumption Value (2021-2032)
2.7 South Korea Immunity Support Ingredients Consumption Value (2021-2032)
2.8 ASEAN Immunity Support Ingredients Consumption Value (2021-2032)
2.9 India Immunity Support Ingredients Consumption Value (2021-2032)
3 WORLD IMMUNITY SUPPORT INGREDIENTS COMPANIES COMPETITIVE ANALYSIS
3.1 World Immunity Support Ingredients Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Immunity Support Ingredients Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Immunity Support Ingredients in 2025
3.2.3 Global Concentration Ratios (CR8) for Immunity Support Ingredients in 2025
3.3 Immunity Support Ingredients Company Evaluation Quadrant
3.4 Immunity Support Ingredients Market: Overall Company Footprint Analysis
3.4.1 Immunity Support Ingredients Market: Region Footprint
3.4.2 Immunity Support Ingredients Market: Company Product Type Footprint
3.4.3 Immunity Support Ingredients Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Immunity Support Ingredients Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Immunity Support Ingredients Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Immunity Support Ingredients Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Immunity Support Ingredients Consumption Value Comparison
4.2.1 United States VS China: Immunity Support Ingredients Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Immunity Support Ingredients Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Immunity Support Ingredients Companies and Market Share, 2021-2026
4.3.1 United States Based Immunity Support Ingredients Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Immunity Support Ingredients Revenue, (2021-2026)
4.4 China Based Companies Immunity Support Ingredients Revenue and Market Share, 2021-2026
4.4.1 China Based Immunity Support Ingredients Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Immunity Support Ingredients Revenue, (2021-2026)
4.5 Rest of World Based Immunity Support Ingredients Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Immunity Support Ingredients Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Immunity Support Ingredients Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Immunity Support Ingredients Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Vitamin C
5.2.2 Vitamin E
5.2.3 Other Vitamins
5.2.4 Beta Glucans
5.2.5 Carotenoids
5.2.6 Phytosterols
5.2.7 Omega-3 Fatty Acids
5.3 Market Segment by Type
5.3.1 World Immunity Support Ingredients Market Size by Type (2021-2026)
5.3.2 World Immunity Support Ingredients Market Size by Type (2027-2032)
5.3.3 World Immunity Support Ingredients Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Immunity Support Ingredients Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Liquid
6.2.2 Powder
6.2.3 Capsule/Tablet
6.3 Market Segment by Dosage Form
6.3.1 World Immunity Support Ingredients Market Size by Dosage Form (2021-2026)
6.3.2 World Immunity Support Ingredients Market Size by Dosage Form (2027-2032)
6.3.3 World Immunity Support Ingredients Market Size Market Share by Dosage Form (2027-2032)
7 MARKET ANALYSIS BY PURITY
7.1 World Immunity Support Ingredients Market Size Overview by Purity: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Purity
7.2.1 ?95%
7.2.2 ?98%
7.2.3 ?99%
7.2.4 Other
7.3 Market Segment by Purity
7.3.1 World Immunity Support Ingredients Market Size by Purity (2021-2026)
7.3.2 World Immunity Support Ingredients Market Size by Purity (2027-2032)
7.3.3 World Immunity Support Ingredients Market Size Market Share by Purity (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Immunity Support Ingredients Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Nutrition Supplements
8.2.2 Foods & Beverages
8.2.3 Pharmaceuticals
8.2.4 Feeds
8.2.5 Pet Foods
8.2.6 Personal Care Products
8.2.7 Other
8.3 Market Segment by Application
8.3.1 World Immunity Support Ingredients Market Size by Application (2021-2026)
8.3.2 World Immunity Support Ingredients Market Size by Application (2027-2032)
8.3.3 World Immunity Support Ingredients Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 DSM (NL)
9.1.1 DSM (NL) Details
9.1.2 DSM (NL) Major Business
9.1.3 DSM (NL) Immunity Support Ingredients Product and Services
9.1.4 DSM (NL) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 DSM (NL) Recent Developments/Updates
9.1.6 DSM (NL) Competitive Strengths & Weaknesses
9.2 BASF SE (DE)
9.2.1 BASF SE (DE) Details
9.2.2 BASF SE (DE) Major Business
9.2.3 BASF SE (DE) Immunity Support Ingredients Product and Services
9.2.4 BASF SE (DE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 BASF SE (DE) Recent Developments/Updates
9.2.6 BASF SE (DE) Competitive Strengths & Weaknesses
9.3 Archer Daniels Midland Company (US)
9.3.1 Archer Daniels Midland Company (US) Details
9.3.2 Archer Daniels Midland Company (US) Major Business
9.3.3 Archer Daniels Midland Company (US) Immunity Support Ingredients Product and Services
9.3.4 Archer Daniels Midland Company (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Archer Daniels Midland Company (US) Recent Developments/Updates
9.3.6 Archer Daniels Midland Company (US) Competitive Strengths & Weaknesses
9.4 International Flavors & Fragrances Inc. (US)
9.4.1 International Flavors & Fragrances Inc. (US) Details
9.4.2 International Flavors & Fragrances Inc. (US) Major Business
9.4.3 International Flavors & Fragrances Inc. (US) Immunity Support Ingredients Product and Services
9.4.4 International Flavors & Fragrances Inc. (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 International Flavors & Fragrances Inc. (US) Recent Developments/Updates
9.4.6 International Flavors & Fragrances Inc. (US) Competitive Strengths & Weaknesses
9.5 Kerry Group plc (IE)
9.5.1 Kerry Group plc (IE) Details
9.5.2 Kerry Group plc (IE) Major Business
9.5.3 Kerry Group plc (IE) Immunity Support Ingredients Product and Services
9.5.4 Kerry Group plc (IE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Kerry Group plc (IE) Recent Developments/Updates
9.5.6 Kerry Group plc (IE) Competitive Strengths & Weaknesses
9.6 Novonesis (DK)
9.6.1 Novonesis (DK) Details
9.6.2 Novonesis (DK) Major Business
9.6.3 Novonesis (DK) Immunity Support Ingredients Product and Services
9.6.4 Novonesis (DK) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Novonesis (DK) Recent Developments/Updates
9.6.6 Novonesis (DK) Competitive Strengths & Weaknesses
9.7 FrieslandCampina Ingredients (NL)
9.7.1 FrieslandCampina Ingredients (NL) Details
9.7.2 FrieslandCampina Ingredients (NL) Major Business
9.7.3 FrieslandCampina Ingredients (NL) Immunity Support Ingredients Product and Services
9.7.4 FrieslandCampina Ingredients (NL) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 FrieslandCampina Ingredients (NL) Recent Developments/Updates
9.7.6 FrieslandCampina Ingredients (NL) Competitive Strengths & Weaknesses
9.8 Fonterra Co-operative Group Limited (NZ)
9.8.1 Fonterra Co-operative Group Limited (NZ) Details
9.8.2 Fonterra Co-operative Group Limited (NZ) Major Business
9.8.3 Fonterra Co-operative Group Limited (NZ) Immunity Support Ingredients Product and Services
9.8.4 Fonterra Co-operative Group Limited (NZ) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Fonterra Co-operative Group Limited (NZ) Recent Developments/Updates
9.8.6 Fonterra Co-operative Group Limited (NZ) Competitive Strengths & Weaknesses
9.9 Arla Foods Ingredients Group P/S (DK)
9.9.1 Arla Foods Ingredients Group P/S (DK) Details
9.9.2 Arla Foods Ingredients Group P/S (DK) Major Business
9.9.3 Arla Foods Ingredients Group P/S (DK) Immunity Support Ingredients Product and Services
9.9.4 Arla Foods Ingredients Group P/S (DK) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Arla Foods Ingredients Group P/S (DK) Recent Developments/Updates
9.9.6 Arla Foods Ingredients Group P/S (DK) Competitive Strengths & Weaknesses
9.10 BENEO GmbH (DE)
9.10.1 BENEO GmbH (DE) Details
9.10.2 BENEO GmbH (DE) Major Business
9.10.3 BENEO GmbH (DE) Immunity Support Ingredients Product and Services
9.10.4 BENEO GmbH (DE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 BENEO GmbH (DE) Recent Developments/Updates
9.10.6 BENEO GmbH (DE) Competitive Strengths & Weaknesses
9.11 Angel Yeast Co., Ltd. (CN)
9.11.1 Angel Yeast Co., Ltd. (CN) Details
9.11.2 Angel Yeast Co., Ltd. (CN) Major Business
9.11.3 Angel Yeast Co., Ltd. (CN) Immunity Support Ingredients Product and Services
9.11.4 Angel Yeast Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Angel Yeast Co., Ltd. (CN) Recent Developments/Updates
9.11.6 Angel Yeast Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.12 Lesaffre (FR)
9.12.1 Lesaffre (FR) Details
9.12.2 Lesaffre (FR) Major Business
9.12.3 Lesaffre (FR) Immunity Support Ingredients Product and Services
9.12.4 Lesaffre (FR) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Lesaffre (FR) Recent Developments/Updates
9.12.6 Lesaffre (FR) Competitive Strengths & Weaknesses
9.13 Balchem Corporation (US)
9.13.1 Balchem Corporation (US) Details
9.13.2 Balchem Corporation (US) Major Business
9.13.3 Balchem Corporation (US) Immunity Support Ingredients Product and Services
9.13.4 Balchem Corporation (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Balchem Corporation (US) Recent Developments/Updates
9.13.6 Balchem Corporation (US) Competitive Strengths & Weaknesses
9.14 Glanbia plc (IE)
9.14.1 Glanbia plc (IE) Details
9.14.2 Glanbia plc (IE) Major Business
9.14.3 Glanbia plc (IE) Immunity Support Ingredients Product and Services
9.14.4 Glanbia plc (IE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Glanbia plc (IE) Recent Developments/Updates
9.14.6 Glanbia plc (IE) Competitive Strengths & Weaknesses
9.15 MartinBauer Group (US)
9.15.1 MartinBauer Group (US) Details
9.15.2 MartinBauer Group (US) Major Business
9.15.3 MartinBauer Group (US) Immunity Support Ingredients Product and Services
9.15.4 MartinBauer Group (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 MartinBauer Group (US) Recent Developments/Updates
9.15.6 MartinBauer Group (US) Competitive Strengths & Weaknesses
9.16 Indena S.p.A. (IT)
9.16.1 Indena S.p.A. (IT) Details
9.16.2 Indena S.p.A. (IT) Major Business
9.16.3 Indena S.p.A. (IT) Immunity Support Ingredients Product and Services
9.16.4 Indena S.p.A. (IT) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Indena S.p.A. (IT) Recent Developments/Updates
9.16.6 Indena S.p.A. (IT) Competitive Strengths & Weaknesses
9.17 Sabinsa Corporation (US)
9.17.1 Sabinsa Corporation (US) Details
9.17.2 Sabinsa Corporation (US) Major Business
9.17.3 Sabinsa Corporation (US) Immunity Support Ingredients Product and Services
9.17.4 Sabinsa Corporation (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Sabinsa Corporation (US) Recent Developments/Updates
9.17.6 Sabinsa Corporation (US) Competitive Strengths & Weaknesses
9.18 Euromed S.A. (ES)
9.18.1 Euromed S.A. (ES) Details
9.18.2 Euromed S.A. (ES) Major Business
9.18.3 Euromed S.A. (ES) Immunity Support Ingredients Product and Services
9.18.4 Euromed S.A. (ES) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Euromed S.A. (ES) Recent Developments/Updates
9.18.6 Euromed S.A. (ES) Competitive Strengths & Weaknesses
9.19 Probi AB (SE)
9.19.1 Probi AB (SE) Details
9.19.2 Probi AB (SE) Major Business
9.19.3 Probi AB (SE) Immunity Support Ingredients Product and Services
9.19.4 Probi AB (SE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Probi AB (SE) Recent Developments/Updates
9.19.6 Probi AB (SE) Competitive Strengths & Weaknesses
9.20 BioGaia AB (SE)
9.20.1 BioGaia AB (SE) Details
9.20.2 BioGaia AB (SE) Major Business
9.20.3 BioGaia AB (SE) Immunity Support Ingredients Product and Services
9.20.4 BioGaia AB (SE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 BioGaia AB (SE) Recent Developments/Updates
9.20.6 BioGaia AB (SE) Competitive Strengths & Weaknesses
9.21 Morinaga Milk Industry Co., Ltd. (JP)
9.21.1 Morinaga Milk Industry Co., Ltd. (JP) Details
9.21.2 Morinaga Milk Industry Co., Ltd. (JP) Major Business
9.21.3 Morinaga Milk Industry Co., Ltd. (JP) Immunity Support Ingredients Product and Services
9.21.4 Morinaga Milk Industry Co., Ltd. (JP) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Morinaga Milk Industry Co., Ltd. (JP) Recent Developments/Updates
9.21.6 Morinaga Milk Industry Co., Ltd. (JP) Competitive Strengths & Weaknesses
9.22 Lallemand Inc. (CA)
9.22.1 Lallemand Inc. (CA) Details
9.22.2 Lallemand Inc. (CA) Major Business
9.22.3 Lallemand Inc. (CA) Immunity Support Ingredients Product and Services
9.22.4 Lallemand Inc. (CA) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Lallemand Inc. (CA) Recent Developments/Updates
9.22.6 Lallemand Inc. (CA) Competitive Strengths & Weaknesses
9.23 Zhejiang NHU Co., Ltd. (CN)
9.23.1 Zhejiang NHU Co., Ltd. (CN) Details
9.23.2 Zhejiang NHU Co., Ltd. (CN) Major Business
9.23.3 Zhejiang NHU Co., Ltd. (CN) Immunity Support Ingredients Product and Services
9.23.4 Zhejiang NHU Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Zhejiang NHU Co., Ltd. (CN) Recent Developments/Updates
9.23.6 Zhejiang NHU Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.24 CSPC Pharmaceutical Group Limited (CN)
9.24.1 CSPC Pharmaceutical Group Limited (CN) Details
9.24.2 CSPC Pharmaceutical Group Limited (CN) Major Business
9.24.3 CSPC Pharmaceutical Group Limited (CN) Immunity Support Ingredients Product and Services
9.24.4 CSPC Pharmaceutical Group Limited (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 CSPC Pharmaceutical Group Limited (CN) Recent Developments/Updates
9.24.6 CSPC Pharmaceutical Group Limited (CN) Competitive Strengths & Weaknesses
9.25 Northeast Pharmaceutical Group Co., Ltd. (CN)
9.25.1 Northeast Pharmaceutical Group Co., Ltd. (CN) Details
9.25.2 Northeast Pharmaceutical Group Co., Ltd. (CN) Major Business
9.25.3 Northeast Pharmaceutical Group Co., Ltd. (CN) Immunity Support Ingredients Product and Services
9.25.4 Northeast Pharmaceutical Group Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Northeast Pharmaceutical Group Co., Ltd. (CN) Recent Developments/Updates
9.25.6 Northeast Pharmaceutical Group Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.26 Zhejiang Medicine Co., Ltd. (CN)
9.26.1 Zhejiang Medicine Co., Ltd. (CN) Details
9.26.2 Zhejiang Medicine Co., Ltd. (CN) Major Business
9.26.3 Zhejiang Medicine Co., Ltd. (CN) Immunity Support Ingredients Product and Services
9.26.4 Zhejiang Medicine Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Zhejiang Medicine Co., Ltd. (CN) Recent Developments/Updates
9.26.6 Zhejiang Medicine Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.27 Roquette Fr?res (FR)
9.27.1 Roquette Fr?res (FR) Details
9.27.2 Roquette Fr?res (FR) Major Business
9.27.3 Roquette Fr?res (FR) Immunity Support Ingredients Product and Services
9.27.4 Roquette Fr?res (FR) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Roquette Fr?res (FR) Recent Developments/Updates
9.27.6 Roquette Fr?res (FR) Competitive Strengths & Weaknesses
9.28 Tate & Lyle PLC (GB)
9.28.1 Tate & Lyle PLC (GB) Details
9.28.2 Tate & Lyle PLC (GB) Major Business
9.28.3 Tate & Lyle PLC (GB) Immunity Support Ingredients Product and Services
9.28.4 Tate & Lyle PLC (GB) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Tate & Lyle PLC (GB) Recent Developments/Updates
9.28.6 Tate & Lyle PLC (GB) Competitive Strengths & Weaknesses
9.29 Hunan Green-Spring Biotechnology Co., Ltd. (CN)
9.29.1 Hunan Green-Spring Biotechnology Co., Ltd. (CN) Details
9.29.2 Hunan Green-Spring Biotechnology Co., Ltd. (CN) Major Business
9.29.3 Hunan Green-Spring Biotechnology Co., Ltd. (CN) Immunity Support Ingredients Product and Services
9.29.4 Hunan Green-Spring Biotechnology Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 Hunan Green-Spring Biotechnology Co., Ltd. (CN) Recent Developments/Updates
9.29.6 Hunan Green-Spring Biotechnology Co., Ltd. (CN) Competitive Strengths & Weaknesses
9.30 Croda International Plc (GB)
9.30.1 Croda International Plc (GB) Details
9.30.2 Croda International Plc (GB) Major Business
9.30.3 Croda International Plc (GB) Immunity Support Ingredients Product and Services
9.30.4 Croda International Plc (GB) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Croda International Plc (GB) Recent Developments/Updates
9.30.6 Croda International Plc (GB) Competitive Strengths & Weaknesses
9.31 EPAX AS (NO)
9.31.1 EPAX AS (NO) Details
9.31.2 EPAX AS (NO) Major Business
9.31.3 EPAX AS (NO) Immunity Support Ingredients Product and Services
9.31.4 EPAX AS (NO) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 EPAX AS (NO) Recent Developments/Updates
9.31.6 EPAX AS (NO) Competitive Strengths & Weaknesses
9.32 Bluestar Adisseo Company (CN)
9.32.1 Bluestar Adisseo Company (CN) Details
9.32.2 Bluestar Adisseo Company (CN) Major Business
9.32.3 Bluestar Adisseo Company (CN) Immunity Support Ingredients Product and Services
9.32.4 Bluestar Adisseo Company (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 Bluestar Adisseo Company (CN) Recent Developments/Updates
9.32.6 Bluestar Adisseo Company (CN) Competitive Strengths & Weaknesses
9.33 Raisio plc (FI)
9.33.1 Raisio plc (FI) Details
9.33.2 Raisio plc (FI) Major Business
9.33.3 Raisio plc (FI) Immunity Support Ingredients Product and Services
9.33.4 Raisio plc (FI) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 Raisio plc (FI) Recent Developments/Updates
9.33.6 Raisio plc (FI) Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Immunity Support Ingredients Industry Chain
10.2 Immunity Support Ingredients Upstream Analysis
10.3 Immunity Support Ingredients Midstream Analysis
10.4 Immunity Support Ingredients Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Immunity Support Ingredients Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Immunity Support Ingredients Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Immunity Support Ingredients Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Immunity Support Ingredients Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Immunity Support Ingredients Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Immunity Support Ingredients Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Immunity Support Ingredients Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Immunity Support Ingredients Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Immunity Support Ingredients Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Immunity Support Ingredients Players in 2025
Table 12. World Immunity Support Ingredients Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Immunity Support Ingredients Company Evaluation Quadrant
Table 14. Head Office of Key Immunity Support Ingredients Players
Table 15. Immunity Support Ingredients Market: Company Product Type Footprint
Table 16. Immunity Support Ingredients Market: Company Product Application Footprint
Table 17. Immunity Support Ingredients Mergers & Acquisitions Activity
Table 18. United States VS China Immunity Support Ingredients Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Immunity Support Ingredients Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Immunity Support Ingredients Companies, Headquarters (States, Country)
Table 21. United States Based Companies Immunity Support Ingredients Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Immunity Support Ingredients Revenue Market Share (2021-2026)
Table 23. China Based Immunity Support Ingredients Companies, Headquarters (Province, Country)
Table 24. China Based Companies Immunity Support Ingredients Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Immunity Support Ingredients Revenue Market Share (2021-2026)
Table 26. Rest of World Based Immunity Support Ingredients Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Immunity Support Ingredients Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Immunity Support Ingredients Revenue Market Share (2021-2026)
Table 29. World Immunity Support Ingredients Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Immunity Support Ingredients Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Immunity Support Ingredients Market Size by Type (2027-2032) & (USD Million)
Table 32. World Immunity Support Ingredients Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 33. World Immunity Support Ingredients Market Size Value by Dosage Form (2021-2026) & (USD Million)
Table 34. World Immunity Support Ingredients Market Size by Dosage Form (2027-2032) & (USD Million)
Table 35. World Immunity Support Ingredients Market Size by Purity, (USD Million), 2021 & 2025 & 2032
Table 36. World Immunity Support Ingredients Market Size Value by Purity (2021-2026) & (USD Million)
Table 37. World Immunity Support Ingredients Market Size by Purity (2027-2032) & (USD Million)
Table 38. World Immunity Support Ingredients Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Immunity Support Ingredients Market Size by Application (2021-2026) & (USD Million)
Table 40. World Immunity Support Ingredients Market Size by Application (2027-2032) & (USD Million)
Table 41. DSM (NL) Basic Information, Manufacturing Base and Competitors
Table 42. DSM (NL) Major Business
Table 43. DSM (NL) Immunity Support Ingredients Product and Services
Table 44. DSM (NL) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. DSM (NL) Recent Developments/Updates
Table 46. DSM (NL) Competitive Strengths & Weaknesses
Table 47. BASF SE (DE) Basic Information, Manufacturing Base and Competitors
Table 48. BASF SE (DE) Major Business
Table 49. BASF SE (DE) Immunity Support Ingredients Product and Services
Table 50. BASF SE (DE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. BASF SE (DE) Recent Developments/Updates
Table 52. BASF SE (DE) Competitive Strengths & Weaknesses
Table 53. Archer Daniels Midland Company (US) Basic Information, Manufacturing Base and Competitors
Table 54. Archer Daniels Midland Company (US) Major Business
Table 55. Archer Daniels Midland Company (US) Immunity Support Ingredients Product and Services
Table 56. Archer Daniels Midland Company (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Archer Daniels Midland Company (US) Recent Developments/Updates
Table 58. Archer Daniels Midland Company (US) Competitive Strengths & Weaknesses
Table 59. International Flavors & Fragrances Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 60. International Flavors & Fragrances Inc. (US) Major Business
Table 61. International Flavors & Fragrances Inc. (US) Immunity Support Ingredients Product and Services
Table 62. International Flavors & Fragrances Inc. (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. International Flavors & Fragrances Inc. (US) Recent Developments/Updates
Table 64. International Flavors & Fragrances Inc. (US) Competitive Strengths & Weaknesses
Table 65. Kerry Group plc (IE) Basic Information, Manufacturing Base and Competitors
Table 66. Kerry Group plc (IE) Major Business
Table 67. Kerry Group plc (IE) Immunity Support Ingredients Product and Services
Table 68. Kerry Group plc (IE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Kerry Group plc (IE) Recent Developments/Updates
Table 70. Kerry Group plc (IE) Competitive Strengths & Weaknesses
Table 71. Novonesis (DK) Basic Information, Manufacturing Base and Competitors
Table 72. Novonesis (DK) Major Business
Table 73. Novonesis (DK) Immunity Support Ingredients Product and Services
Table 74. Novonesis (DK) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Novonesis (DK) Recent Developments/Updates
Table 76. Novonesis (DK) Competitive Strengths & Weaknesses
Table 77. FrieslandCampina Ingredients (NL) Basic Information, Manufacturing Base and Competitors
Table 78. FrieslandCampina Ingredients (NL) Major Business
Table 79. FrieslandCampina Ingredients (NL) Immunity Support Ingredients Product and Services
Table 80. FrieslandCampina Ingredients (NL) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. FrieslandCampina Ingredients (NL) Recent Developments/Updates
Table 82. FrieslandCampina Ingredients (NL) Competitive Strengths & Weaknesses
Table 83. Fonterra Co-operative Group Limited (NZ) Basic Information, Manufacturing Base and Competitors
Table 84. Fonterra Co-operative Group Limited (NZ) Major Business
Table 85. Fonterra Co-operative Group Limited (NZ) Immunity Support Ingredients Product and Services
Table 86. Fonterra Co-operative Group Limited (NZ) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Fonterra Co-operative Group Limited (NZ) Recent Developments/Updates
Table 88. Fonterra Co-operative Group Limited (NZ) Competitive Strengths & Weaknesses
Table 89. Arla Foods Ingredients Group P/S (DK) Basic Information, Manufacturing Base and Competitors
Table 90. Arla Foods Ingredients Group P/S (DK) Major Business
Table 91. Arla Foods Ingredients Group P/S (DK) Immunity Support Ingredients Product and Services
Table 92. Arla Foods Ingredients Group P/S (DK) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Arla Foods Ingredients Group P/S (DK) Recent Developments/Updates
Table 94. Arla Foods Ingredients Group P/S (DK) Competitive Strengths & Weaknesses
Table 95. BENEO GmbH (DE) Basic Information, Manufacturing Base and Competitors
Table 96. BENEO GmbH (DE) Major Business
Table 97. BENEO GmbH (DE) Immunity Support Ingredients Product and Services
Table 98. BENEO GmbH (DE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. BENEO GmbH (DE) Recent Developments/Updates
Table 100. BENEO GmbH (DE) Competitive Strengths & Weaknesses
Table 101. Angel Yeast Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 102. Angel Yeast Co., Ltd. (CN) Major Business
Table 103. Angel Yeast Co., Ltd. (CN) Immunity Support Ingredients Product and Services
Table 104. Angel Yeast Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Angel Yeast Co., Ltd. (CN) Recent Developments/Updates
Table 106. Angel Yeast Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 107. Lesaffre (FR) Basic Information, Manufacturing Base and Competitors
Table 108. Lesaffre (FR) Major Business
Table 109. Lesaffre (FR) Immunity Support Ingredients Product and Services
Table 110. Lesaffre (FR) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Lesaffre (FR) Recent Developments/Updates
Table 112. Lesaffre (FR) Competitive Strengths & Weaknesses
Table 113. Balchem Corporation (US) Basic Information, Manufacturing Base and Competitors
Table 114. Balchem Corporation (US) Major Business
Table 115. Balchem Corporation (US) Immunity Support Ingredients Product and Services
Table 116. Balchem Corporation (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Balchem Corporation (US) Recent Developments/Updates
Table 118. Balchem Corporation (US) Competitive Strengths & Weaknesses
Table 119. Glanbia plc (IE) Basic Information, Manufacturing Base and Competitors
Table 120. Glanbia plc (IE) Major Business
Table 121. Glanbia plc (IE) Immunity Support Ingredients Product and Services
Table 122. Glanbia plc (IE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Glanbia plc (IE) Recent Developments/Updates
Table 124. Glanbia plc (IE) Competitive Strengths & Weaknesses
Table 125. MartinBauer Group (US) Basic Information, Manufacturing Base and Competitors
Table 126. MartinBauer Group (US) Major Business
Table 127. MartinBauer Group (US) Immunity Support Ingredients Product and Services
Table 128. MartinBauer Group (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. MartinBauer Group (US) Recent Developments/Updates
Table 130. MartinBauer Group (US) Competitive Strengths & Weaknesses
Table 131. Indena S.p.A. (IT) Basic Information, Manufacturing Base and Competitors
Table 132. Indena S.p.A. (IT) Major Business
Table 133. Indena S.p.A. (IT) Immunity Support Ingredients Product and Services
Table 134. Indena S.p.A. (IT) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Indena S.p.A. (IT) Recent Developments/Updates
Table 136. Indena S.p.A. (IT) Competitive Strengths & Weaknesses
Table 137. Sabinsa Corporation (US) Basic Information, Manufacturing Base and Competitors
Table 138. Sabinsa Corporation (US) Major Business
Table 139. Sabinsa Corporation (US) Immunity Support Ingredients Product and Services
Table 140. Sabinsa Corporation (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Sabinsa Corporation (US) Recent Developments/Updates
Table 142. Sabinsa Corporation (US) Competitive Strengths & Weaknesses
Table 143. Euromed S.A. (ES) Basic Information, Manufacturing Base and Competitors
Table 144. Euromed S.A. (ES) Major Business
Table 145. Euromed S.A. (ES) Immunity Support Ingredients Product and Services
Table 146. Euromed S.A. (ES) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Euromed S.A. (ES) Recent Developments/Updates
Table 148. Euromed S.A. (ES) Competitive Strengths & Weaknesses
Table 149. Probi AB (SE) Basic Information, Manufacturing Base and Competitors
Table 150. Probi AB (SE) Major Business
Table 151. Probi AB (SE) Immunity Support Ingredients Product and Services
Table 152. Probi AB (SE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Probi AB (SE) Recent Developments/Updates
Table 154. Probi AB (SE) Competitive Strengths & Weaknesses
Table 155. BioGaia AB (SE) Basic Information, Manufacturing Base and Competitors
Table 156. BioGaia AB (SE) Major Business
Table 157. BioGaia AB (SE) Immunity Support Ingredients Product and Services
Table 158. BioGaia AB (SE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. BioGaia AB (SE) Recent Developments/Updates
Table 160. BioGaia AB (SE) Competitive Strengths & Weaknesses
Table 161. Morinaga Milk Industry Co., Ltd. (JP) Basic Information, Manufacturing Base and Competitors
Table 162. Morinaga Milk Industry Co., Ltd. (JP) Major Business
Table 163. Morinaga Milk Industry Co., Ltd. (JP) Immunity Support Ingredients Product and Services
Table 164. Morinaga Milk Industry Co., Ltd. (JP) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Morinaga Milk Industry Co., Ltd. (JP) Recent Developments/Updates
Table 166. Morinaga Milk Industry Co., Ltd. (JP) Competitive Strengths & Weaknesses
Table 167. Lallemand Inc. (CA) Basic Information, Manufacturing Base and Competitors
Table 168. Lallemand Inc. (CA) Major Business
Table 169. Lallemand Inc. (CA) Immunity Support Ingredients Product and Services
Table 170. Lallemand Inc. (CA) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Lallemand Inc. (CA) Recent Developments/Updates
Table 172. Lallemand Inc. (CA) Competitive Strengths & Weaknesses
Table 173. Zhejiang NHU Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 174. Zhejiang NHU Co., Ltd. (CN) Major Business
Table 175. Zhejiang NHU Co., Ltd. (CN) Immunity Support Ingredients Product and Services
Table 176. Zhejiang NHU Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Zhejiang NHU Co., Ltd. (CN) Recent Developments/Updates
Table 178. Zhejiang NHU Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 179. CSPC Pharmaceutical Group Limited (CN) Basic Information, Manufacturing Base and Competitors
Table 180. CSPC Pharmaceutical Group Limited (CN) Major Business
Table 181. CSPC Pharmaceutical Group Limited (CN) Immunity Support Ingredients Product and Services
Table 182. CSPC Pharmaceutical Group Limited (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. CSPC Pharmaceutical Group Limited (CN) Recent Developments/Updates
Table 184. CSPC Pharmaceutical Group Limited (CN) Competitive Strengths & Weaknesses
Table 185. Northeast Pharmaceutical Group Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 186. Northeast Pharmaceutical Group Co., Ltd. (CN) Major Business
Table 187. Northeast Pharmaceutical Group Co., Ltd. (CN) Immunity Support Ingredients Product and Services
Table 188. Northeast Pharmaceutical Group Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Northeast Pharmaceutical Group Co., Ltd. (CN) Recent Developments/Updates
Table 190. Northeast Pharmaceutical Group Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 191. Zhejiang Medicine Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 192. Zhejiang Medicine Co., Ltd. (CN) Major Business
Table 193. Zhejiang Medicine Co., Ltd. (CN) Immunity Support Ingredients Product and Services
Table 194. Zhejiang Medicine Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Zhejiang Medicine Co., Ltd. (CN) Recent Developments/Updates
Table 196. Zhejiang Medicine Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 197. Roquette Fr?res (FR) Basic Information, Manufacturing Base and Competitors
Table 198. Roquette Fr?res (FR) Major Business
Table 199. Roquette Fr?res (FR) Immunity Support Ingredients Product and Services
Table 200. Roquette Fr?res (FR) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Roquette Fr?res (FR) Recent Developments/Updates
Table 202. Roquette Fr?res (FR) Competitive Strengths & Weaknesses
Table 203. Tate & Lyle PLC (GB) Basic Information, Manufacturing Base and Competitors
Table 204. Tate & Lyle PLC (GB) Major Business
Table 205. Tate & Lyle PLC (GB) Immunity Support Ingredients Product and Services
Table 206. Tate & Lyle PLC (GB) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Tate & Lyle PLC (GB) Recent Developments/Updates
Table 208. Tate & Lyle PLC (GB) Competitive Strengths & Weaknesses
Table 209. Hunan Green-Spring Biotechnology Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 210. Hunan Green-Spring Biotechnology Co., Ltd. (CN) Major Business
Table 211. Hunan Green-Spring Biotechnology Co., Ltd. (CN) Immunity Support Ingredients Product and Services
Table 212. Hunan Green-Spring Biotechnology Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. Hunan Green-Spring Biotechnology Co., Ltd. (CN) Recent Developments/Updates
Table 214. Hunan Green-Spring Biotechnology Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 215. Croda International Plc (GB) Basic Information, Manufacturing Base and Competitors
Table 216. Croda International Plc (GB) Major Business
Table 217. Croda International Plc (GB) Immunity Support Ingredients Product and Services
Table 218. Croda International Plc (GB) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Croda International Plc (GB) Recent Developments/Updates
Table 220. Croda International Plc (GB) Competitive Strengths & Weaknesses
Table 221. EPAX AS (NO) Basic Information, Manufacturing Base and Competitors
Table 222. EPAX AS (NO) Major Business
Table 223. EPAX AS (NO) Immunity Support Ingredients Product and Services
Table 224. EPAX AS (NO) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. EPAX AS (NO) Recent Developments/Updates
Table 226. EPAX AS (NO) Competitive Strengths & Weaknesses
Table 227. Bluestar Adisseo Company (CN) Basic Information, Manufacturing Base and Competitors
Table 228. Bluestar Adisseo Company (CN) Major Business
Table 229. Bluestar Adisseo Company (CN) Immunity Support Ingredients Product and Services
Table 230. Bluestar Adisseo Company (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. Bluestar Adisseo Company (CN) Recent Developments/Updates
Table 232. Bluestar Adisseo Company (CN) Competitive Strengths & Weaknesses
Table 233. Raisio plc (FI) Basic Information, Manufacturing Base and Competitors
Table 234. Raisio plc (FI) Major Business
Table 235. Raisio plc (FI) Immunity Support Ingredients Product and Services
Table 236. Raisio plc (FI) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. Raisio plc (FI) Recent Developments/Updates
Table 238. Raisio plc (FI) Competitive Strengths & Weaknesses
Table 239. Global Key Players of Immunity Support Ingredients Upstream (Raw Materials)
Table 240. Global Immunity Support Ingredients Typical Customers
Table 1. World Immunity Support Ingredients Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Immunity Support Ingredients Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Immunity Support Ingredients Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Immunity Support Ingredients Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Immunity Support Ingredients Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Immunity Support Ingredients Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Immunity Support Ingredients Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Immunity Support Ingredients Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Immunity Support Ingredients Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Immunity Support Ingredients Players in 2025
Table 12. World Immunity Support Ingredients Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Immunity Support Ingredients Company Evaluation Quadrant
Table 14. Head Office of Key Immunity Support Ingredients Players
Table 15. Immunity Support Ingredients Market: Company Product Type Footprint
Table 16. Immunity Support Ingredients Market: Company Product Application Footprint
Table 17. Immunity Support Ingredients Mergers & Acquisitions Activity
Table 18. United States VS China Immunity Support Ingredients Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Immunity Support Ingredients Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Immunity Support Ingredients Companies, Headquarters (States, Country)
Table 21. United States Based Companies Immunity Support Ingredients Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Immunity Support Ingredients Revenue Market Share (2021-2026)
Table 23. China Based Immunity Support Ingredients Companies, Headquarters (Province, Country)
Table 24. China Based Companies Immunity Support Ingredients Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Immunity Support Ingredients Revenue Market Share (2021-2026)
Table 26. Rest of World Based Immunity Support Ingredients Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Immunity Support Ingredients Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Immunity Support Ingredients Revenue Market Share (2021-2026)
Table 29. World Immunity Support Ingredients Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Immunity Support Ingredients Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Immunity Support Ingredients Market Size by Type (2027-2032) & (USD Million)
Table 32. World Immunity Support Ingredients Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 33. World Immunity Support Ingredients Market Size Value by Dosage Form (2021-2026) & (USD Million)
Table 34. World Immunity Support Ingredients Market Size by Dosage Form (2027-2032) & (USD Million)
Table 35. World Immunity Support Ingredients Market Size by Purity, (USD Million), 2021 & 2025 & 2032
Table 36. World Immunity Support Ingredients Market Size Value by Purity (2021-2026) & (USD Million)
Table 37. World Immunity Support Ingredients Market Size by Purity (2027-2032) & (USD Million)
Table 38. World Immunity Support Ingredients Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Immunity Support Ingredients Market Size by Application (2021-2026) & (USD Million)
Table 40. World Immunity Support Ingredients Market Size by Application (2027-2032) & (USD Million)
Table 41. DSM (NL) Basic Information, Manufacturing Base and Competitors
Table 42. DSM (NL) Major Business
Table 43. DSM (NL) Immunity Support Ingredients Product and Services
Table 44. DSM (NL) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. DSM (NL) Recent Developments/Updates
Table 46. DSM (NL) Competitive Strengths & Weaknesses
Table 47. BASF SE (DE) Basic Information, Manufacturing Base and Competitors
Table 48. BASF SE (DE) Major Business
Table 49. BASF SE (DE) Immunity Support Ingredients Product and Services
Table 50. BASF SE (DE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. BASF SE (DE) Recent Developments/Updates
Table 52. BASF SE (DE) Competitive Strengths & Weaknesses
Table 53. Archer Daniels Midland Company (US) Basic Information, Manufacturing Base and Competitors
Table 54. Archer Daniels Midland Company (US) Major Business
Table 55. Archer Daniels Midland Company (US) Immunity Support Ingredients Product and Services
Table 56. Archer Daniels Midland Company (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Archer Daniels Midland Company (US) Recent Developments/Updates
Table 58. Archer Daniels Midland Company (US) Competitive Strengths & Weaknesses
Table 59. International Flavors & Fragrances Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 60. International Flavors & Fragrances Inc. (US) Major Business
Table 61. International Flavors & Fragrances Inc. (US) Immunity Support Ingredients Product and Services
Table 62. International Flavors & Fragrances Inc. (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. International Flavors & Fragrances Inc. (US) Recent Developments/Updates
Table 64. International Flavors & Fragrances Inc. (US) Competitive Strengths & Weaknesses
Table 65. Kerry Group plc (IE) Basic Information, Manufacturing Base and Competitors
Table 66. Kerry Group plc (IE) Major Business
Table 67. Kerry Group plc (IE) Immunity Support Ingredients Product and Services
Table 68. Kerry Group plc (IE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Kerry Group plc (IE) Recent Developments/Updates
Table 70. Kerry Group plc (IE) Competitive Strengths & Weaknesses
Table 71. Novonesis (DK) Basic Information, Manufacturing Base and Competitors
Table 72. Novonesis (DK) Major Business
Table 73. Novonesis (DK) Immunity Support Ingredients Product and Services
Table 74. Novonesis (DK) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Novonesis (DK) Recent Developments/Updates
Table 76. Novonesis (DK) Competitive Strengths & Weaknesses
Table 77. FrieslandCampina Ingredients (NL) Basic Information, Manufacturing Base and Competitors
Table 78. FrieslandCampina Ingredients (NL) Major Business
Table 79. FrieslandCampina Ingredients (NL) Immunity Support Ingredients Product and Services
Table 80. FrieslandCampina Ingredients (NL) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. FrieslandCampina Ingredients (NL) Recent Developments/Updates
Table 82. FrieslandCampina Ingredients (NL) Competitive Strengths & Weaknesses
Table 83. Fonterra Co-operative Group Limited (NZ) Basic Information, Manufacturing Base and Competitors
Table 84. Fonterra Co-operative Group Limited (NZ) Major Business
Table 85. Fonterra Co-operative Group Limited (NZ) Immunity Support Ingredients Product and Services
Table 86. Fonterra Co-operative Group Limited (NZ) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Fonterra Co-operative Group Limited (NZ) Recent Developments/Updates
Table 88. Fonterra Co-operative Group Limited (NZ) Competitive Strengths & Weaknesses
Table 89. Arla Foods Ingredients Group P/S (DK) Basic Information, Manufacturing Base and Competitors
Table 90. Arla Foods Ingredients Group P/S (DK) Major Business
Table 91. Arla Foods Ingredients Group P/S (DK) Immunity Support Ingredients Product and Services
Table 92. Arla Foods Ingredients Group P/S (DK) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Arla Foods Ingredients Group P/S (DK) Recent Developments/Updates
Table 94. Arla Foods Ingredients Group P/S (DK) Competitive Strengths & Weaknesses
Table 95. BENEO GmbH (DE) Basic Information, Manufacturing Base and Competitors
Table 96. BENEO GmbH (DE) Major Business
Table 97. BENEO GmbH (DE) Immunity Support Ingredients Product and Services
Table 98. BENEO GmbH (DE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. BENEO GmbH (DE) Recent Developments/Updates
Table 100. BENEO GmbH (DE) Competitive Strengths & Weaknesses
Table 101. Angel Yeast Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 102. Angel Yeast Co., Ltd. (CN) Major Business
Table 103. Angel Yeast Co., Ltd. (CN) Immunity Support Ingredients Product and Services
Table 104. Angel Yeast Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Angel Yeast Co., Ltd. (CN) Recent Developments/Updates
Table 106. Angel Yeast Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 107. Lesaffre (FR) Basic Information, Manufacturing Base and Competitors
Table 108. Lesaffre (FR) Major Business
Table 109. Lesaffre (FR) Immunity Support Ingredients Product and Services
Table 110. Lesaffre (FR) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Lesaffre (FR) Recent Developments/Updates
Table 112. Lesaffre (FR) Competitive Strengths & Weaknesses
Table 113. Balchem Corporation (US) Basic Information, Manufacturing Base and Competitors
Table 114. Balchem Corporation (US) Major Business
Table 115. Balchem Corporation (US) Immunity Support Ingredients Product and Services
Table 116. Balchem Corporation (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Balchem Corporation (US) Recent Developments/Updates
Table 118. Balchem Corporation (US) Competitive Strengths & Weaknesses
Table 119. Glanbia plc (IE) Basic Information, Manufacturing Base and Competitors
Table 120. Glanbia plc (IE) Major Business
Table 121. Glanbia plc (IE) Immunity Support Ingredients Product and Services
Table 122. Glanbia plc (IE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Glanbia plc (IE) Recent Developments/Updates
Table 124. Glanbia plc (IE) Competitive Strengths & Weaknesses
Table 125. MartinBauer Group (US) Basic Information, Manufacturing Base and Competitors
Table 126. MartinBauer Group (US) Major Business
Table 127. MartinBauer Group (US) Immunity Support Ingredients Product and Services
Table 128. MartinBauer Group (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. MartinBauer Group (US) Recent Developments/Updates
Table 130. MartinBauer Group (US) Competitive Strengths & Weaknesses
Table 131. Indena S.p.A. (IT) Basic Information, Manufacturing Base and Competitors
Table 132. Indena S.p.A. (IT) Major Business
Table 133. Indena S.p.A. (IT) Immunity Support Ingredients Product and Services
Table 134. Indena S.p.A. (IT) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Indena S.p.A. (IT) Recent Developments/Updates
Table 136. Indena S.p.A. (IT) Competitive Strengths & Weaknesses
Table 137. Sabinsa Corporation (US) Basic Information, Manufacturing Base and Competitors
Table 138. Sabinsa Corporation (US) Major Business
Table 139. Sabinsa Corporation (US) Immunity Support Ingredients Product and Services
Table 140. Sabinsa Corporation (US) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Sabinsa Corporation (US) Recent Developments/Updates
Table 142. Sabinsa Corporation (US) Competitive Strengths & Weaknesses
Table 143. Euromed S.A. (ES) Basic Information, Manufacturing Base and Competitors
Table 144. Euromed S.A. (ES) Major Business
Table 145. Euromed S.A. (ES) Immunity Support Ingredients Product and Services
Table 146. Euromed S.A. (ES) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Euromed S.A. (ES) Recent Developments/Updates
Table 148. Euromed S.A. (ES) Competitive Strengths & Weaknesses
Table 149. Probi AB (SE) Basic Information, Manufacturing Base and Competitors
Table 150. Probi AB (SE) Major Business
Table 151. Probi AB (SE) Immunity Support Ingredients Product and Services
Table 152. Probi AB (SE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Probi AB (SE) Recent Developments/Updates
Table 154. Probi AB (SE) Competitive Strengths & Weaknesses
Table 155. BioGaia AB (SE) Basic Information, Manufacturing Base and Competitors
Table 156. BioGaia AB (SE) Major Business
Table 157. BioGaia AB (SE) Immunity Support Ingredients Product and Services
Table 158. BioGaia AB (SE) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. BioGaia AB (SE) Recent Developments/Updates
Table 160. BioGaia AB (SE) Competitive Strengths & Weaknesses
Table 161. Morinaga Milk Industry Co., Ltd. (JP) Basic Information, Manufacturing Base and Competitors
Table 162. Morinaga Milk Industry Co., Ltd. (JP) Major Business
Table 163. Morinaga Milk Industry Co., Ltd. (JP) Immunity Support Ingredients Product and Services
Table 164. Morinaga Milk Industry Co., Ltd. (JP) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Morinaga Milk Industry Co., Ltd. (JP) Recent Developments/Updates
Table 166. Morinaga Milk Industry Co., Ltd. (JP) Competitive Strengths & Weaknesses
Table 167. Lallemand Inc. (CA) Basic Information, Manufacturing Base and Competitors
Table 168. Lallemand Inc. (CA) Major Business
Table 169. Lallemand Inc. (CA) Immunity Support Ingredients Product and Services
Table 170. Lallemand Inc. (CA) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Lallemand Inc. (CA) Recent Developments/Updates
Table 172. Lallemand Inc. (CA) Competitive Strengths & Weaknesses
Table 173. Zhejiang NHU Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 174. Zhejiang NHU Co., Ltd. (CN) Major Business
Table 175. Zhejiang NHU Co., Ltd. (CN) Immunity Support Ingredients Product and Services
Table 176. Zhejiang NHU Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Zhejiang NHU Co., Ltd. (CN) Recent Developments/Updates
Table 178. Zhejiang NHU Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 179. CSPC Pharmaceutical Group Limited (CN) Basic Information, Manufacturing Base and Competitors
Table 180. CSPC Pharmaceutical Group Limited (CN) Major Business
Table 181. CSPC Pharmaceutical Group Limited (CN) Immunity Support Ingredients Product and Services
Table 182. CSPC Pharmaceutical Group Limited (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. CSPC Pharmaceutical Group Limited (CN) Recent Developments/Updates
Table 184. CSPC Pharmaceutical Group Limited (CN) Competitive Strengths & Weaknesses
Table 185. Northeast Pharmaceutical Group Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 186. Northeast Pharmaceutical Group Co., Ltd. (CN) Major Business
Table 187. Northeast Pharmaceutical Group Co., Ltd. (CN) Immunity Support Ingredients Product and Services
Table 188. Northeast Pharmaceutical Group Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Northeast Pharmaceutical Group Co., Ltd. (CN) Recent Developments/Updates
Table 190. Northeast Pharmaceutical Group Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 191. Zhejiang Medicine Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 192. Zhejiang Medicine Co., Ltd. (CN) Major Business
Table 193. Zhejiang Medicine Co., Ltd. (CN) Immunity Support Ingredients Product and Services
Table 194. Zhejiang Medicine Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Zhejiang Medicine Co., Ltd. (CN) Recent Developments/Updates
Table 196. Zhejiang Medicine Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 197. Roquette Fr?res (FR) Basic Information, Manufacturing Base and Competitors
Table 198. Roquette Fr?res (FR) Major Business
Table 199. Roquette Fr?res (FR) Immunity Support Ingredients Product and Services
Table 200. Roquette Fr?res (FR) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Roquette Fr?res (FR) Recent Developments/Updates
Table 202. Roquette Fr?res (FR) Competitive Strengths & Weaknesses
Table 203. Tate & Lyle PLC (GB) Basic Information, Manufacturing Base and Competitors
Table 204. Tate & Lyle PLC (GB) Major Business
Table 205. Tate & Lyle PLC (GB) Immunity Support Ingredients Product and Services
Table 206. Tate & Lyle PLC (GB) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Tate & Lyle PLC (GB) Recent Developments/Updates
Table 208. Tate & Lyle PLC (GB) Competitive Strengths & Weaknesses
Table 209. Hunan Green-Spring Biotechnology Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 210. Hunan Green-Spring Biotechnology Co., Ltd. (CN) Major Business
Table 211. Hunan Green-Spring Biotechnology Co., Ltd. (CN) Immunity Support Ingredients Product and Services
Table 212. Hunan Green-Spring Biotechnology Co., Ltd. (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. Hunan Green-Spring Biotechnology Co., Ltd. (CN) Recent Developments/Updates
Table 214. Hunan Green-Spring Biotechnology Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 215. Croda International Plc (GB) Basic Information, Manufacturing Base and Competitors
Table 216. Croda International Plc (GB) Major Business
Table 217. Croda International Plc (GB) Immunity Support Ingredients Product and Services
Table 218. Croda International Plc (GB) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Croda International Plc (GB) Recent Developments/Updates
Table 220. Croda International Plc (GB) Competitive Strengths & Weaknesses
Table 221. EPAX AS (NO) Basic Information, Manufacturing Base and Competitors
Table 222. EPAX AS (NO) Major Business
Table 223. EPAX AS (NO) Immunity Support Ingredients Product and Services
Table 224. EPAX AS (NO) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. EPAX AS (NO) Recent Developments/Updates
Table 226. EPAX AS (NO) Competitive Strengths & Weaknesses
Table 227. Bluestar Adisseo Company (CN) Basic Information, Manufacturing Base and Competitors
Table 228. Bluestar Adisseo Company (CN) Major Business
Table 229. Bluestar Adisseo Company (CN) Immunity Support Ingredients Product and Services
Table 230. Bluestar Adisseo Company (CN) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. Bluestar Adisseo Company (CN) Recent Developments/Updates
Table 232. Bluestar Adisseo Company (CN) Competitive Strengths & Weaknesses
Table 233. Raisio plc (FI) Basic Information, Manufacturing Base and Competitors
Table 234. Raisio plc (FI) Major Business
Table 235. Raisio plc (FI) Immunity Support Ingredients Product and Services
Table 236. Raisio plc (FI) Immunity Support Ingredients Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. Raisio plc (FI) Recent Developments/Updates
Table 238. Raisio plc (FI) Competitive Strengths & Weaknesses
Table 239. Global Key Players of Immunity Support Ingredients Upstream (Raw Materials)
Table 240. Global Immunity Support Ingredients Typical Customers
LIST OF FIGURES
Figure 1. Immunity Support Ingredients Picture
Figure 2. World Immunity Support Ingredients Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Immunity Support Ingredients Total Revenue (2021-2032) & (USD Million)
Figure 4. World Immunity Support Ingredients Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Immunity Support Ingredients Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 13. Immunity Support Ingredients Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 16. World Immunity Support Ingredients Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 18. China Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 23. India Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Immunity Support Ingredients by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Immunity Support Ingredients Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Immunity Support Ingredients Markets in 2025
Figure 27. United States VS China: Immunity Support Ingredients Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Immunity Support Ingredients Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Immunity Support Ingredients Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Immunity Support Ingredients Market Size Market Share by Type in 2025
Figure 31. Vitamin C
Figure 32. Vitamin E
Figure 33. Other Vitamins
Figure 34. Beta Glucans
Figure 35. Carotenoids
Figure 36. Phytosterols
Figure 37. Omega-3 Fatty Acids
Figure 38. Omega-3 Fatty Acids
Figure 39. World Immunity Support Ingredients Market Size Market Share by Type (2021-2032)
Figure 40. World Immunity Support Ingredients Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 41. World Immunity Support Ingredients Market Size Market Share by Dosage Form in 2025
Figure 42. Liquid
Figure 43. Powder
Figure 44. Capsule/Tablet
Figure 45. World Immunity Support Ingredients Market Size Market Share by Dosage Form (2021-2032)
Figure 46. World Immunity Support Ingredients Market Size by Purity, (USD Million), 2021 & 2025 & 2032
Figure 47. World Immunity Support Ingredients Market Size Market Share by Purity in 2025
Figure 48. ?95%
Figure 49. ?98%
Figure 50. ?99%
Figure 51. Other
Figure 52. World Immunity Support Ingredients Market Size Market Share by Purity (2021-2032)
Figure 53. World Immunity Support Ingredients Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Immunity Support Ingredients Market Size Market Share by Application in 2025
Figure 55. Nutrition Supplements
Figure 56. Foods & Beverages
Figure 57. Pharmaceuticals
Figure 58. Feeds
Figure 59. Pet Foods
Figure 60. Personal Care Products
Figure 61. Other
Figure 62. World Immunity Support Ingredients Market Size Market Share by Application (2021-2032)
Figure 63. Immunity Support Ingredients Industrial Chain
Figure 64. Methodology
Figure 65. Research Process and Data Source
Figure 1. Immunity Support Ingredients Picture
Figure 2. World Immunity Support Ingredients Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Immunity Support Ingredients Total Revenue (2021-2032) & (USD Million)
Figure 4. World Immunity Support Ingredients Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Immunity Support Ingredients Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Immunity Support Ingredients Revenue (2021-2032) & (USD Million)
Figure 13. Immunity Support Ingredients Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 16. World Immunity Support Ingredients Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 18. China Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 23. India Immunity Support Ingredients Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Immunity Support Ingredients by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Immunity Support Ingredients Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Immunity Support Ingredients Markets in 2025
Figure 27. United States VS China: Immunity Support Ingredients Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Immunity Support Ingredients Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Immunity Support Ingredients Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Immunity Support Ingredients Market Size Market Share by Type in 2025
Figure 31. Vitamin C
Figure 32. Vitamin E
Figure 33. Other Vitamins
Figure 34. Beta Glucans
Figure 35. Carotenoids
Figure 36. Phytosterols
Figure 37. Omega-3 Fatty Acids
Figure 38. Omega-3 Fatty Acids
Figure 39. World Immunity Support Ingredients Market Size Market Share by Type (2021-2032)
Figure 40. World Immunity Support Ingredients Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 41. World Immunity Support Ingredients Market Size Market Share by Dosage Form in 2025
Figure 42. Liquid
Figure 43. Powder
Figure 44. Capsule/Tablet
Figure 45. World Immunity Support Ingredients Market Size Market Share by Dosage Form (2021-2032)
Figure 46. World Immunity Support Ingredients Market Size by Purity, (USD Million), 2021 & 2025 & 2032
Figure 47. World Immunity Support Ingredients Market Size Market Share by Purity in 2025
Figure 48. ?95%
Figure 49. ?98%
Figure 50. ?99%
Figure 51. Other
Figure 52. World Immunity Support Ingredients Market Size Market Share by Purity (2021-2032)
Figure 53. World Immunity Support Ingredients Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Immunity Support Ingredients Market Size Market Share by Application in 2025
Figure 55. Nutrition Supplements
Figure 56. Foods & Beverages
Figure 57. Pharmaceuticals
Figure 58. Feeds
Figure 59. Pet Foods
Figure 60. Personal Care Products
Figure 61. Other
Figure 62. World Immunity Support Ingredients Market Size Market Share by Application (2021-2032)
Figure 63. Immunity Support Ingredients Industrial Chain
Figure 64. Methodology
Figure 65. Research Process and Data Source
